PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
+18.91%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$87M
AUM Growth
+$87M
(+16%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 80.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UroGen Pharma
URGN
$885M
| $54.5M | 62.61% |
1,096,024
| – | – |
|
2
Mersana Therapeutics
MRSN
$36.2M
| $15.1M | 17.33% |
955,709
| – | – |
|
|
AGRX
3
DELISTED
Agile Therapeutics, Inc
AGRX
| $13M | 14.96% |
5,062,363
| – | – |
|
|
IMDZ
4
DELISTED
Immune Design Corp.
IMDZ
| $4.08M | 4.69% |
1,236,394
| – | – |
|
|
EGRX
5
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $357K | 0.41% |
6,777
| – | – |
|